Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 44Pancreatic Neoplasms 39Rectal Neoplasms 20Colonic Neoplasms 19Stomach Neoplasms 18Neoplasm Metastasis 16Esophageal Neoplasms 13Cholangiocarcinoma 13Barrett Esophagus 11Carcinoma, Hepatocellular 10Ovarian Neoplasms 9Breast Neoplasms 9Adenocarcinoma Of Esophagus 9Melanoma 8Anus Neoplasms 8Neoplasms 7Sarcoma 6Lung Neoplasms 6Liver Neoplasms 6Glioma 6Gastroesophageal Reflux 6Gallbladder Neoplasms 6Uterine Cervical Neoplasms 5Lymphoma, Non-Hodgkin 5Hepatoblastoma 5Esophageal Squamous Cell Carcinoma 5Endometrial Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenomatous Polyposis Coli 5Wilms Tumor 4

Interventions

obeticholic acid 1Specimen Handling 1Erlotinib Hydrochloride 1Endoscopy, Gastrointestinal 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Attenuated familial adenomatous polyposis × Biopsy × Gastrointestinal × Clear all
NCT05223036 2026-05-14

Testing Obeticholic Acid for Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Terminated
15 enrolled
Gastrointestinal

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡